Community/Retail

For the fourth consecutive year, the National Community Pharmacists Association (NCPA) has asked its members to rank their most important legislative and regulatory priorities.

The drug failed to demonstrate a statistically significant difference from placebo in the change from baseline of the investigator rating of the Conners’ Adult ADHD Rating Scales (CAARS).

The FDA is allowing the sale of EU-approved Panretin gel (alitretinoin 0.1%) tubes in the United States due to a shortage of the US-approved gel.

Five years after the deadly outbreak, the owner and former head pharmacist of the NECC faces charges for racketeering, mail fraud, and murder.

The new guidelines put forth a looser diagnostic treatment threshold for average and low-risk adults.

Walgreens has announced that it has made naloxone available without a prescription in all of its Arizona pharmacies in accordance with state pharmacy regulations.

This popular bipartisan legislation aims to increase access to health care in rural areas.

Senators Chuck Grassley, Bob Casey, and Sherrod Brown last week re-introduced legislation that urges pharmacists to provide care for elderly patients in communities where being seen by a physician may be difficult.

Pharmacists are a great resource for families, especially on medication safety issues.

The Annals of Pharmacotherapy published a study that examines the association between antioxidant vitamin supplement use and AD risk.

The membership of the Pharmacy Quality Alliance has endorsed two new performance measures: Concurrent Use of Opioids and Benzodiazepines and Adherence to Non-Infused Disease Modifying Agents Used to Treat Multiple Sclerosis.

HPV infection is preventable with immunization, but even though the HPV vaccine has been available for 10 years, uptake is far lower than acceptable.

Vaccines are extremely topical, with questions routinely being asked, particularly during the winter season.

The FDA has approved the investigational new drug application from Keystone Nano for Ceramide NanoLiposome to assess the product as a form of treatment for solid tumors.

The Department of Health and Human Services has released information that shows that millions of seniors and people with disabilities with Medicare continue to save on prescription drugs and see improved benefits in 2016 as a result of the Affordable Care Act.

The FDA has given clearance to NeuroRx to proceed with a phase 2B/3 study protocol under an investigational new drug application for NRX-101, the first oral therapy for acute suicidal ideation and behavior (ASIB).

A Pennsylvania hospital has agreed to pay $510,000 in fines after an inpatient pharmacist stole controlled substances.

A new report released by the National Academies of Sciences, Engineering, and Medicine (NAS) sets forth an objective offering of key evidence surrounding the benefits and harms of cannabis use.

Continuous glucose monitors (CGMs) may soon be eligible for coverage by the US Centers for Medicare and Medicaid Services (CMS).

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Philadelphia's

According to IMS health 57 million prescriptions for gabapentin were written in the U.S. in 2015, a 42% increase since 2011.

HRA Pharma has partnered with Ibis Reproductive Health to conduct research and submit a new drug application for an OTC progestin-only pill to the FDA.

The Pharmacy and Medically Underserved Areas Enhancement Act (S. 109) was reintroduced today with the bipartisan original co-sponsorship of more than one-quarter of the U.S. Senate.

The FDA has not issued an approval for the drug and it is not indicated to treat any conditions.

As President-elect Donald Trump and congressional Republicans prepare their efforts to dismantle the Affordable Care Act, the NCPA has penned a letter to key representatives outlining its recommendations for future health care reform.